Another drug stock tanks on Citron short threat By: CNBC.com News November 09, 2015 at 14:42 PM EST Shares of Mallinckrodt fell as much as 25 percent after Citron Research tweeted the company had more downside than Valeant at these levels. Read More >> Related Stocks: Mallinckrodt plc